- Home
- KARD vs PDM Comparison
KARD vs PDM Comparison
Compare KARD & PDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KARD | PDM |
|---|---|---|
| Founded | 2023 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Building operators |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2026 | 1997 |
Fundamental Metrics
Financial Performance| Metric | KARD | PDM |
|---|---|---|
| Price | $14.10 | $9.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $41.00 | $10.75 |
| AVG Volume (30 Days) | 577.7K | ★ 1.3M |
| Earning Date | 11-22-2026 | 10-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $564,994,000.00 |
| Revenue This Year | N/A | $3.70 |
| Revenue Next Year | $50.00 | $1.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.23 | $6.32 |
| 52 Week High | $27.00 | $10.13 |
Technical Indicators
Market Signals| Indicator | KARD | PDM |
|---|---|---|
| Relative Strength Index (RSI) | 47.93 | 62.24 |
| Support Level | $13.75 | $9.28 |
| Resistance Level | $15.93 | $9.97 |
| Average True Range (ATR) | 0.99 | 0.26 |
| MACD | 0.32 | 0.07 |
| Stochastic Oscillator | 68.52 | 97.64 |
Price Performance
Historical ComparisonAbout KARD Kardigan Inc. Common Stock
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
About PDM Piedmont Office Realty Trust Inc.
Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.